As superbugs threaten to create a global crisis, why are pharmaceutical companies shying away from antibiotics research.

JULIA BRADSHAW | April 15, 2019

article image
“China is a horror, India is a mega-horror,” says Alan Westwood, managing director of Matoke, a company hoping to develop a new form of antibiotic. “Russia is terrible. Don’t get sick in Greece either, the resistance rates are big, and in southern Europe generally.” Antibiotic resistance is one of the biggest threats to human health. In 30 years, it’s estimated 10m people will die annually from infections impervious to what have been the most powerful weapons in our pharmaceutical arsenal. This is more than the combined number of people dying today from cancer and diabetes. The West benefits from reasonably responsible antibiotic use and resistance rates are relatively low.

Spotlight

Healthcare Improvement Scotland

We believe that every person in Scotland should receive the best healthcare possible every time you come into contact with your health service. We are the national healthcare improvement organisation for Scotland and part of NHSScotland. We work with staff who provide care in hospitals, GP practices, clinics, NHS boards and with patients, carers, communities and the public.

OTHER ARTICLES

Pharmacist eCare Plan - the newest disrupter in health data exchange?

Article | February 25, 2020

Every member of the health care team shares a common goal of optimizing patient outcomes. Yet each specialty and position of the healthcare team has a unique workflow facilitated by various tools, from an operative report to a progress note. In this regard the pharmacist plays a pivotal function in medication management and requires documentation specific to that role. The Pharmacist eCare Plan (PeCP) allows for an interoperable note to be used in the pharmacy to assist in the exchange of patient information, including active medication list, laboratory results, and payer information. To allow for this, a new type of clinical document architecture for the PeCP was created and standardized for use across pharmacies.

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 6, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

What are the advantages of PCD Pharma Company?

Article | February 17, 2020

PCD Pharma stands for propaganda distribution. A PCD company gives brand name and support to its franchises. They also provide distribution rights and monopoly rights within a particular region. If a person wants to establish their business, it is a must for them to know the pros and cons of the business to make a sound decision. Needless to mention that PCD company has a lot to contribute in the medical filed. Worldwide in a medical field, A PCD Pharma Company is playing an essential and crucial role in the rapid growth. The pharma industry is progressing t a fast pace. The company uses the latest technologies for each brand which ensures the safety of products and accepts the responsibility of human health & life by providing better outcomes. To have a drug license number and company registration, the cost to establish the company is quite cost-effective that is15000-20000rs. So this gives people a brilliant opportunity to have their unit without digging a big hole in their bank balance. Indian produces exquisite quality products, which make pharma companies a considerable success.

Read More

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | April 6, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

Spotlight

Healthcare Improvement Scotland

We believe that every person in Scotland should receive the best healthcare possible every time you come into contact with your health service. We are the national healthcare improvement organisation for Scotland and part of NHSScotland. We work with staff who provide care in hospitals, GP practices, clinics, NHS boards and with patients, carers, communities and the public.

Events